Veos Pharmaceuticals is a global biotechnology company operating across Europe and North America, combining research, regulatory expertise, and market execution to deliver products and platforms across multiple industries.
Regulated health products and therapeutic innovation across ophthalmics, nasal conditions, and general health for adults and pediatrics.
Water treatment, odor control, and sustainability solutions built on natural waste-source chemistry for cleaner environments.
Crop performance and soil health technologies that improve agricultural efficiency and support resilient, sustainable food systems.
Natural preservation systems for industrial applications — clean-label, science-backed solutions for food and beverage manufacturers.
Veos's ophthalmic portfolio spans hydroxypropyl methylcellulose, sodium hyaluronate, carbomer, and chamomile/euphrasia-based formulations — covering dry-eye relief, lubrication, and preservative-free single-dose convenience.
Enhances crop protein production, improves soil health, and increases crop resilience for global food security.
Prevents muscle atrophy in aging, GLP-1 users, and chronic-condition patients via patented myostatin regulation.
Olive-based Liquid Intelligent odor & water Quenching — natural waste-source chemistry for cleaner environments.
Clean-label, natural preservative for beverages — proprietary 2-component formulation extending shelf life.
We work with distributors, manufacturers, research institutions, and clinical partners across Europe and North America to bring scientific innovation to market.